Effects of Sport Stacking on Cognition in Patients With Mild Alzheimer's Disease and MCI: Preliminary Findings of Randomized Controlled Trial

被引:1
|
作者
Yang, Ziying [1 ]
Yang, Jun [2 ]
Yu, Doris S. F. [3 ]
Liu, Dunxiu [2 ]
Ding, Fu [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Nursing, 1 Youyi Rd, Chongqing 400042, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 1, Dept Gen Practice, Chongqing, Peoples R China
[3] Univ Hong Kong, Li Ka Shing Fac Med, Sch Nursing, Hong Kong, Peoples R China
关键词
sport stacking; Alzheimer's disease; mild cognitive impairment; cognition; aging; PHYSICAL-ACTIVITY; IMPAIRMENT; DEMENTIA; PARTICIPATION; PROGRAM; MOTOR; EXERCISE; RISK; COORDINATION; INDIVIDUALS;
D O I
10.1177/08919887231195227
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: This mixed-method pilot study aims to investigate the feasibility and preliminary effects of sport stacking on cognitive function in individuals with mild Alzheimer's disease (AD) and those with mild cognitive impairment (MCI). Methods: Twenty-four community-dwelling subjects with confirmed mild AD or MCI were evenly randomly assigned to either the 12-week sport stacking intervention group (n = 12) or clinic routine management control group (n = 12). Outcome evaluation included the Auditory Verbal Learning Test (AVLT), Alzheimer's Disease Cooperative Study-Activities of Daily Living scale (ADCS-ADL), and plasma brain-derived neurotrophic factor (BDNF). A qualitative descriptive study was conducted to explore the overall perception and experience of the sport stacking from the subjects' perspective. Results: Twenty-two subjects completed the trial. At 12 weeks post-intervention, compared to the control group, the sport stacking group had significantly greater improvements in AVLT immediate recall (P < .001, Cohen d = .66) and an increase in plasma BDNF (P < .001, Cohen d = .64). Subgroup analysis indicated that subjects with MCI had significantly greater increases in AVLT immediate recall (P = .005, Cohen d = .72), ADCS-ADL (P = .130, Cohen d = .42) and plasma BDNF (P = .024, Cohen d = .83). Twelve subjects participating in the post-intervention interviews expressed the benefits (e.g., hand-eye coordination and faster reaction) from sport stacking and their enjoyment of it. Conclusion: To the best of our knowledge, this is the first study indicating that sport stacking is feasible among individuals with MCI and mild AD. The preliminary effect on episodic memory is encouraging, possibly via upregulation of BDNF.
引用
收藏
页码:24 / 38
页数:15
相关论文
共 50 条
  • [31] Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial
    Peskind, ER
    Potkin, SG
    Pomara, N
    Ott, BR
    McDonald, S
    Xie, Y
    Gergel, I
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S332 - S332
  • [32] Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial
    Peskind, E. R.
    Potkin, S. G.
    Pomara, N.
    Ott, B. R.
    McDonald, S.
    Xie, Y.
    Gergel, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 187 - 187
  • [33] Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial
    Peskind, ER
    Potkin, SG
    Pomara, N
    Ott, BR
    McDonald, S
    Xie, Y
    Gergel, I
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S207 - S207
  • [34] Memantine, monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial
    Pomara, N
    Peskind, ER
    Potkin, SG
    McDonald, S
    Xie, Y
    Gergel, I
    NEUROBIOLOGY OF AGING, 2004, 25 : S19 - S19
  • [36] Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease
    Egan, Michael F.
    Kost, James
    Tariot, Pierre N.
    Aisen, Paul S.
    Cummings, Jeffrey L.
    Vellas, Bruno
    Sur, Cyrille
    Mukai, Yuki
    Voss, Tiffini
    Furtek, Christine
    Mahoney, Erin
    Mozley, Lyn Harper
    Vandenberghe, Rik
    Mo, Yi
    Michelson, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (18): : 1691 - 1703
  • [37] The Role of Greek Olive Leaf Extract in Patients with Mild Alzheimer's Disease (the GOLDEN Study): A Randomized Controlled Clinical Trial
    Loukou, Sofia
    Papantoniou, Georgia
    Pantazaki, Anastasia
    Tsolaki, Magdalini
    NEUROLOGY INTERNATIONAL, 2024, 16 (06): : 1247 - 1265
  • [38] Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial
    Akhondzadeh, S.
    Shafiee-Sabet, M.
    Harirchian, M. H.
    Togha, M.
    Cheraghmakani, H.
    Razeghi, S.
    Hejazi, S. Sh
    Yousefi, M. H.
    Alimardani, R.
    Jamshidi, A.
    Zare, F.
    Moradi, A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (05) : 581 - 588
  • [39] TRanscranial AlterNating current stimulation FOR patients with mild Alzheimer's Disease (TRANSFORM-AD): a randomized controlled clinical trial
    Tang, Yi
    Xing, Yi
    Sun, Liwei
    Wang, Zhibin
    Wang, Changming
    Yang, Kun
    Zhu, Wei
    Shi, Xinrui
    Xie, Beijia
    Yin, Yunsi
    Mi, Yingxin
    Wei, Tao
    Tong, Renjie
    Qiao, Yuchen
    Yan, Shaozhen
    Wei, Penghu
    Yang, Yanfeng
    Shan, Yongzhi
    Zhang, Xu
    Jia, Jianping
    Teipel, Stefan J.
    Howard, Robert
    Lu, Jie
    Li, Chunlin
    Zhao, Guoguang
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [40] EFFECTS OF ACUPUNCTURE ON SYMPTOMS, MICROBIOTA, AND INFLAMMATION OF PATIENTS WITH MILD TO MODERATE CROHN'S DISEASE: A RANDOMIZED CONTROLLED TRIAL
    Bao, Chunhui
    Liu, Huirong
    Shi, Yin
    Chen, Liming
    Wang, Di
    Li, Guona
    Jin, Xiaoming
    Zeng, Xiaoqing
    Chen, Jianhua
    Zhang, Jingzhi
    Wu, Huangan
    GASTROENTEROLOGY, 2020, 158 (06) : S205 - S205